79 related articles for article (PubMed ID: 23095039)
1. Surgical management in patients with pancreatic cancer: a Queensland perspective.
Wylie N; Adib R; Barbour AP; Fawcett J; Hill A; Lynch S; Martin I; O'Rourke TR; Puhalla H; Rutherford L; Slater K; Whiteman DC; Neale RE;
ANZ J Surg; 2013 Nov; 83(11):859-64. PubMed ID: 23095039
[TBL] [Abstract][Full Text] [Related]
2. Mesenterico-portal vein resection in patients with pancreatico-duodenal cancer is safe and may increase survival.
Storkholm JH; Hansen CP
Dan Med J; 2014 Jan; 61(1):A4757. PubMed ID: 24393587
[TBL] [Abstract][Full Text] [Related]
3. R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use.
Rau BM; Moritz K; Schuschan S; Alsfasser G; Prall F; Klar E
Surgery; 2012 Sep; 152(3 Suppl 1):S103-11. PubMed ID: 22766366
[TBL] [Abstract][Full Text] [Related]
4. Poorly differentiated resectable pancreatic cancer: is upfront resection worthwhile?
Crippa S; Partelli S; Zamboni G; Barugola G; Capelli P; Inama M; Bassi C; Pederzoli P; Falconi M
Surgery; 2012 Sep; 152(3 Suppl 1):S112-9. PubMed ID: 22766365
[TBL] [Abstract][Full Text] [Related]
5. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
Ridwelski K; Meyer F; Schmidt U; Lippert H
Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
[TBL] [Abstract][Full Text] [Related]
6. Long-term survival (5-20 years) after pancreatectomy for pancreatic ductal adenocarcinoma: a series of 30 patients collected from 3 institutions.
Adham M; Jaeck D; Le Borgne J; Oussoultzouglou E; Chenard-Neu MP; Mosnier JF; Scoazec JY; Mornex F; Partensky C
Pancreas; 2008 Nov; 37(4):352-7. PubMed ID: 18665012
[TBL] [Abstract][Full Text] [Related]
7. [Second-look operation in pancreatic carcinoma previously assessed as unresectable].
Warnick P; Bahra M; Andreou A; Neuhaus P; Glanemann M
Zentralbl Chir; 2010 Feb; 135(1):70-4. PubMed ID: 20162503
[TBL] [Abstract][Full Text] [Related]
8. Laparoscopic resection of exocrine carcinoma in central and distal pancreas results in a high rate of radical resections and long postoperative survival.
Marangos IP; Buanes T; Røsok BI; Kazaryan AM; Rosseland AR; Grzyb K; Villanger O; Mathisen Ø; Gladhaug IP; Edwin B
Surgery; 2012 May; 151(5):717-23. PubMed ID: 22284762
[TBL] [Abstract][Full Text] [Related]
9. Surgical outcomes following pancreatic resection at a low-volume community hospital: do all patients need to be sent to a regional cancer center?
Cunningham JD; O'Donnell N; Starker P
Am J Surg; 2009 Aug; 198(2):227-30. PubMed ID: 19306974
[TBL] [Abstract][Full Text] [Related]
10. Follow-up after curative surgery for pancreatic ductal adenocarcinoma: asymptomatic recurrence is associated with improved survival.
Nordby T; Hugenschmidt H; Fagerland MW; Ikdahl T; Buanes T; Labori KJ
Eur J Surg Oncol; 2013 Jun; 39(6):559-66. PubMed ID: 23498362
[TBL] [Abstract][Full Text] [Related]
11. [Surgical treatment of pancreatic carcinoma. Our experience].
Testi W; Coratti A; Tani F; Lorenzi M; Poggialini M; Genovese A; Spagnulo M; Terreni C; Picchianti D; Stefanoni M; Mancini S
Minerva Chir; 2000; 55(7-8):505-12. PubMed ID: 11140104
[TBL] [Abstract][Full Text] [Related]
12. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
[TBL] [Abstract][Full Text] [Related]
13. Improving survival following surgery for pancreatic ductal adenocarcinoma--a ten-year experience.
Hoem D; Viste A
Eur J Surg Oncol; 2012 Mar; 38(3):245-51. PubMed ID: 22217907
[TBL] [Abstract][Full Text] [Related]
14. Clinical presentation and waiting time targets do not affect prognosis in patients with pancreatic cancer.
Raptis DA; Fessas C; Belasyse-Smith P; Kurzawinski TR
Surgeon; 2010 Oct; 8(5):239-46. PubMed ID: 20709279
[TBL] [Abstract][Full Text] [Related]
15. Effect of centralization on long-term survival after resection of pancreatic ductal adenocarcinoma.
Ahola R; Siiki A; Vasama K; Vornanen M; Sand J; Laukkarinen J
Br J Surg; 2017 Oct; 104(11):1532-1538. PubMed ID: 28517236
[TBL] [Abstract][Full Text] [Related]
16. Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy.
Barugola G; Partelli S; Crippa S; Capelli P; D'Onofrio M; Pederzoli P; Falconi M
Am J Surg; 2012 Feb; 203(2):132-9. PubMed ID: 21824596
[TBL] [Abstract][Full Text] [Related]
17. Survival after pancreaticoduodenectomy for periampullary adenocarcinoma: an update.
van Geenen RC; van Gulik TM; Offerhaus GJ; de Wit LT; Busch OR; Obertop H; Gouma DJ
Eur J Surg Oncol; 2001 Sep; 27(6):549-57. PubMed ID: 11520088
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic head resection with segmental duodenectomy: safety and long-term results.
Nakao A; Fernández-Cruz L
Ann Surg; 2007 Dec; 246(6):923-8; discussion 929-31. PubMed ID: 18043093
[TBL] [Abstract][Full Text] [Related]
19. Use of a temporary intraoperative mesentericoportal shunt for pancreatic resection for locally advanced pancreatic cancer with portal vein occlusion and portal hypertension.
Bachellier P; Rosso E; Fuchshuber P; Addeo P; David P; Oussoultzoglou E; Lucescu I
Surgery; 2014 Mar; 155(3):449-56. PubMed ID: 24462078
[TBL] [Abstract][Full Text] [Related]
20. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
Distler M; Pilarsky E; Kersting S; Grützmann R
Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
